Canada - Toronto Stock Exchange - TSX:AH - CA01444Q1046 - Common Stock
The current stock price of AH.CA is 0.02 CAD. In the past month the price decreased by -20%. In the past year, price decreased by -71.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.95 | 3.83B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.48B | ||
| CRON.CA | CRONOS GROUP INC | 24.87 | 1.43B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.14 | 885.62M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 637.44M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.12 | 634.32M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 584.07M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 593.75M | ||
| TSND.CA | TERRASCEND CORP | N/A | 412.44M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 16.99 | 392.22M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 331.14M | ||
| HITI.CA | HIGH TIDE INC | N/A | 323.70M |
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.
Aleafia Health Inc
85 Basaltic Road
Concord ONTARIO L4K 1G4 CA
CEO: Geoffrey M. Benic
Employees: 158
Phone: 19024054600.0
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.
The current stock price of AH.CA is 0.02 CAD.
AH.CA does not pay a dividend.
AH.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Aleafia Health Inc (AH.CA) operates in the Health Care sector and the Pharmaceuticals industry.
The Revenue of Aleafia Health Inc (AH.CA) is expected to grow by 51.58% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a fundamental rating of 2 / 10 to AH.CA. Both the profitability and financial health of AH.CA have multiple concerns.
Over the last trailing twelve months AH.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 79.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.
For the next year, analysts expect an EPS growth of 40% and a revenue growth 51.58% for AH.CA